NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$846M
1-Year Return
19.82%
This Quarter Return
+3.55%
1 Year Return
+19.82%
3 Year Return
+98.28%
5 Year Return
+197.72%
10 Year Return
+449.68%
AUM
$437M
AUM Growth
–
Cap. Flow
+$437M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
16%
Holding
436
New
436
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$13.9M |
| 2 |
Exxon Mobil
XOM
|
$9.49M |
| 3 |
Microsoft
MSFT
|
$7.95M |
| 4 |
JPMorgan Chase
JPM
|
$7.13M |
| 5 |
Procter & Gamble
PG
|
$6.16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 15.13% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 10.93% |
| 5 | Energy | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Parker-Hannifin
PH
$96.2B
| $477K | 0.11% |
+5,000
| New | +$477K |
|
|
URS
302
DELISTED
URS CORP
URS
| $472K | 0.11% |
+10,000
| New | +$472K |
|
303
Verint Systems
VRNT
$1.23B
| $460K | 0.11% |
+25,482
| New | +$460K |
|
304
Xcel Energy
XEL
$43B
| $460K | 0.11% |
+16,243
| New | +$460K |
|
305
Air Products & Chemicals
APD
$64.8B
| $458K | 0.1% |
+5,405
| New | +$458K |
|
306
Viatris
VTRS
$12.1B
| $458K | 0.1% |
+14,750
| New | +$458K |
|
|
TEN
307
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $453K | 0.1% |
+10,000
| New | +$453K |
|
|
EXXI
308
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $444K | 0.1% |
+20,000
| New | +$444K |
|
309
Micron Technology
MU
$144B
| $430K | 0.1% |
+30,000
| New | +$430K |
|
310
Avery Dennison
AVY
$13.1B
| $428K | 0.1% |
+10,000
| New | +$428K |
|
311
Thermo Fisher Scientific
TMO
$186B
| $423K | 0.1% |
+5,000
| New | +$423K |
|
312
Boston Properties
BXP
$12.2B
| $422K | 0.1% |
+4,000
| New | +$422K |
|
|
CPWR
313
DELISTED
COMPUWARE CORP
CPWR
| $414K | 0.09% |
+41,640
| New | +$414K |
|
314
AbbVie
ABBV
$376B
| $413K | 0.09% |
+10,000
| New | +$413K |
|
315
Xerox
XRX
$498M
| $399K | 0.09% |
+16,698
| New | +$399K |
|
316
Ironwood Pharmaceuticals
IRWD
$184M
| $397K | 0.09% |
+47,760
| New | +$397K |
|
317
Dover
DOV
$24.5B
| $388K | 0.09% |
+7,459
| New | +$388K |
|
318
Citigroup
C
$179B
| $384K | 0.09% |
+8,000
| New | +$384K |
|
319
Synopsys
SNPS
$113B
| $384K | 0.09% |
+10,742
| New | +$384K |
|
|
TLAB
320
DELISTED
TELLABS INC
TLAB
| $375K | 0.09% |
+190,000
| New | +$375K |
|
321
Molina Healthcare
MOH
$9.28B
| $372K | 0.09% |
+10,000
| New | +$372K |
|
322
Boston Scientific
BSX
$159B
| $371K | 0.08% |
+40,000
| New | +$371K |
|
323
Opko Health
OPK
$1.08B
| $355K | 0.08% |
+50,000
| New | +$355K |
|
324
Alcoa
AA
$8.25B
| $352K | 0.08% |
+18,727
| New | +$352K |
|
325
Abbott
ABT
$232B
| $349K | 0.08% |
+10,000
| New | +$349K |
|